EULAR Recommendations and Initiatives
The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a group of specialists in their field.
Recommendations should follow the published EULAR SOPs.
Please note that EULAR does not endorse recommendations retrospectively.
Recommendations present relevant evidence to help health professionals in rheumatology weigh the benefits and risks of a particular diagnostic or therapeutic procedure.
Implementation of recommendations in rheumatic and musculoskeletal diseases
PARE: RMDs and COVID-19 repository for patients
The EULAR guidances and an array of useful resources about the current COVID-19 outbreak to give our patients with Rheumatic Musculoskeletal Diseases (RMDs) the best possible care.
Rheumatic Musculoskeletal Diseases and COVID-19 repository for clinicians
The EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2, and an array of useful resources about the current COVID-19 outbreak to give our clinicians the best possible recommendations and support.
EULAR Application for Project Grants
EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.
EULAR Task Forces
EULAR Task Forces bring experts in rheumatology fields together to share expertise and facilitate best practice exchange and ongoing medical development. Discover the fields of EULAR Task Forces and join today.